Bristol Myers Squibb (BMY) Debt Ratio (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Debt Ratio for 16 consecutive years, with 0.5 as the latest value for Q4 2025.

On a quarterly basis, Debt Ratio fell 6.55% to 0.5 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.5, a 6.55% decrease, with the full-year FY2025 number at 0.5, down 6.55% from a year prior.
Debt Ratio was 0.5 for Q4 2025 at Bristol Myers Squibb, down from 0.54 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.56 in Q1 2024 to a low of 0.4 in Q3 2022.
A 4-year average of 0.46 and a median of 0.43 in 2022 define the central range for Debt Ratio.
Peak YoY movement for Debt Ratio: rose 12.68% in 2021, then fell 6.55% in 2025.
Bristol Myers Squibb's Debt Ratio stood at 0.41 in 2021, then decreased by 0.36% to 0.41 in 2022, then skyrocketed by 32.02% to 0.54 in 2024, then decreased by 6.55% to 0.5 in 2025.
Per Business Quant, the three most recent readings for BMY's Debt Ratio are 0.5 (Q4 2025), 0.54 (Q1 2025), and 0.54 (Q4 2024).

Peer Comparison